HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) EVP Michael Mcalevey sold 1,694 shares of the company's stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company's stock, valued at $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
HCA Healthcare Stock Up 0.0%
Shares of NYSE HCA opened at $534.88 on Thursday. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $552.90. The stock has a market cap of $119.61 billion, a P/E ratio of 18.85, a P/E/G ratio of 1.64 and a beta of 1.36. The firm's 50-day simple moving average is $486.13 and its 200 day simple moving average is $452.76.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts' consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.78 dividend. This is an increase from HCA Healthcare's previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare's payout ratio is presently 10.15%.
Hedge Funds Weigh In On HCA Healthcare
A number of institutional investors and hedge funds have recently bought and sold shares of HCA. Brighton Jones LLC bought a new position in HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC raised its position in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock valued at $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC boosted its position in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Chicago Partners Investment Group LLC raised its stake in HCA Healthcare by 228.2% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 3,092 shares of the company's stock valued at $1,092,000 after acquiring an additional 2,150 shares during the period. Finally, Stephens Inc. AR boosted its stake in HCA Healthcare by 3.2% in the 2nd quarter. Stephens Inc. AR now owns 8,500 shares of the company's stock worth $3,256,000 after purchasing an additional 265 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.
Analysts Set New Price Targets
HCA has been the topic of a number of recent research reports. Wells Fargo & Company lifted their target price on HCA Healthcare from $452.00 to $481.00 and gave the stock an "equal weight" rating in a research report on Friday, January 30th. KeyCorp set a $503.00 price target on HCA Healthcare in a research note on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a "buy" rating in a research report on Wednesday, January 28th. Zacks Research cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 27th. Finally, Bank of America increased their price objective on HCA Healthcare from $430.00 to $470.00 and gave the company a "neutral" rating in a report on Monday, October 27th. Sixteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $523.27.
Check Out Our Latest Report on HCA Healthcare
HCA Healthcare News Summary
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: HCA opened a second freestanding emergency room in a Florida county (St. Augustine), expanding local access and potential outpatient/ER revenue streams as the company pushes more care into lower-acuity, higher-margin settings. Becker's: HCA opens 2nd freestanding ER in Florida county MSN: HCA Florida Emergency opens for patients in St. Augustine
- Positive Sentiment: An HCA subsidiary acquired a cardiothoracic and vascular physician group, a deal that should boost patient referrals into HCA hospitals, increase capture of surgical volume, and support revenue growth in high-acuity service lines. Becker's: HCA subsidiary acquires cardiothoracic, vascular physician group
- Positive Sentiment: HCA is investing in EHR unification (alongside peers), an initiative that can lower IT/operational costs, improve care coordination and billing efficiencies — all supportive of margins over time. Becker's: Why Northwell, HCA and UPMC are betting big on EHR unification
- Positive Sentiment: Analyst/style coverage and positive momentum stories (Zacks, Kalkine) highlight HCA as a value/momentum name, which can attract income/value-oriented and momentum-driven flows. Zacks: Here's Why HCA Healthcare is a Strong Value Stock Kalkine: HCA Momentum Shines
- Neutral Sentiment: Discussion pieces and analyst roundups examine where HCA shares may head next; these provide context but are unlikely to move the stock materially absent new guidance or earnings surprises. Yahoo Finance: Are Wall Street Analysts Predicting HCA Stock Will Climb or Sink?
- Neutral Sentiment: Local community/CSR activity (National Wear Red Day with Habitat for Humanity) is positive for brand and community relations but has limited direct impact on near-term financials. Post and Courier: HCA marks National Wear Red Day
- Negative Sentiment: An HCA EVP, Michael R. McAlevey, disclosed a sale of 1,694 shares for about $903k, reducing his holdings ~16% — insider selling can signal personal liquidity needs but may create short-term negative sentiment for investors reading into insider actions. SEC filing: SEC filing: Insider sale
HCA Healthcare Company Profile
(
Get Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
